Trials / Recruiting
RecruitingNCT06274515
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
A Multi Cohort Translational Research Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate mechanisms of resistance to anti-breast cancer therapies in tumor and blood samples from participants with human epidermal growth factor receptor (HER2) positive, hormone receptor (HR) positive or triple negative breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Tumor Tissue and Blood Draw | Participants will have their blood drawn on the day a tissue sample is taken from a progressive tumor lesion. |
Timeline
- Start date
- 2024-04-02
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
- First posted
- 2024-02-23
- Last updated
- 2026-04-06
Locations
28 sites across 8 countries: Belgium, Denmark, Finland, Germany, Italy, Norway, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT06274515. Inclusion in this directory is not an endorsement.